A recent study published in the Indian Journal of Critical Care Medicine presented a case series of patients with coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA). The goal of the study was to inform clinicians and healthcare workers of this serious…

The Society of Cardiovascular Computed Tomography (SCCT) has issued an expert consensus statement to guide use of cardiac computed tomography (CCT) in the care of cardio-oncology patients. This statement addresses “gaps in recommendations on the role of CCT in cancer…

National Eye Institute researchers mapped the organization of human retinal cell chromatin, the fibers that package 3 billion nucleotide-long DNA molecules into compact structures that fit into chromosomes within each cell’s nucleus. The resulting comprehensive gene regulatory network provides insights…

From the first moment I looked into my newborn son’s hazy blue eyes, I knew that I would do anything to protect him. He was so new, so delicate, and though I only had 25 years of my own life…

In a recent study published in JAMA Oncology, investigators from the University of Bergen, in collaboration with the Women’s Health Initiative (WHI) study in the U.S., reported epigenetic gene silencing in normal tissue to be a predictive factor for triple-negative…

A three-drug medication known as a "polypill," developed by the Spanish National Center for Cardiovascular Research (CNIC) and Ferrer, is effective in preventing secondary adverse cardiovascular events in people who have previously had a heart attack, reducing cardiovascular mortality by…

Artivion Inc. has halted the PROACT Xa clinical trial that was testing whether patients with an On-X mechanical aortic valve could be safely and effectively managed with the direct oral anticoagulant (DOAC) apixaban (Eliquis) rather than warfarin. The decision to…

SHANGHAI (Reuters) – China reported 997 new COVID-19 infections on Oct. 20, of which 214 were symptomatic and 783 were asymptomatic, the National Health Commission said on Friday. That compared with 962 new cases a day earlier – 211 symptomatic…

(Reuters) – Amylyx Pharmaceuticals Inc on Friday set the list price of its newly approved drug to treat amyotrophic lateral sclerosis (ALS) at about $158,000 per year in the United States, a discount to its most recently approved competitor. The…

New data from Israel provide further evidence that myocarditis is a rare adverse event of vaccination with the Pfizer/BioNTech mRNA COVID-19 vaccine in adolescents — one that predominantly occurs in males and typically after the second dose. The new data…